New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 7, 2014
17:09 EDTFLXNFlexion reports Q2 EPS (38c), consensus (52c)
News For FLXN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 29, 2014
09:39 EDTFLXNFlexion FDA letter a 'best case' scenario, says Summer Street
Summer Street learned that Flexion recently received its clinical hold letter from the FDA, and after speaking with management, believes the letter confirms a "best case" scenario for the company. The firm says the FDA is requiring Flexion to determine that the infection in the trial was not related to FX006, rather than the more challenging task of determining the ultimate root cause of the infection. It reiterates a Buy rating on the stock with a $28 price target.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use